Other Latest News

• What matters in the API market as 2026 approaches December 2, 2025 11:57 am Pharmaceutical Technology The active pharmaceutical ingredient (API) landscape is shifting. Companies are rethinking their sourcing strategies, upgrading their technological capabilities, and relying more heavily on CDMOs that can deliver resilience, specialism, and speed. In 2024, …
• This chemical stock jumps 77% in 2025 so far; here’s why JM Financial sees more upside November 28, 2025 7:11 am Business Today Brokerage firm JM Financial has maintained its bullish stance on specialty chemicals player Navin Fluorine International. In its latest company update, the domestic brokerage rolled forward its valuation estimates, setting a revised target price of Rs 6, …
• Shift To Biosimilars, $5 Bn Nutraceutical Boom: Pharma Sector's Next BIG Leap November 26, 2025 4:17 pm Zee News India’s pharmaceutical industry is preparing for a transformative leap as it strengthens its global foothold with USD 30 billion in exports, a rapid shift toward biosimilars and complex generics, and a booming USD 5 billion nutraceutical market. From …
• AstraZeneca Shares Leap 9% as Pharma Giant Secures Breakthrough Cancer Drug Approval in UK Market November 24, 2025 10:11 am ABC Money Anglo-Swedish pharmaceutical giant AstraZeneca plc sparked a frenzy in healthcare shares today, with shares soaring more than 9% to 12,500 pence on the London Stock Exchange after the regulators gave the green light to its star oncology treatment, which it …
• The 93rd API China 2025: A Gateway to China’s Pharmaceutical Industry Innovation and Global Collaboration November 19, 2025 6:30 pm Biospectrum Asia The 93rd API China 2025: A Gateway to China’s Pharmaceutical Industry Innovation and Global Collaboration November 20, 2025 | Thursday | News Innovation and Partnership Take Centre Stage at the 93rd Edition of API China in Chongqing Pharma Professionals …
• API China 2025: Pioneering Innovation, Collaboration, and Growth in the Global Pharmaceutical Supply Chain November 19, 2025 6:30 pm Biospectrum Asia API China 2025: Pioneering Innovation, Collaboration, and Growth in the Global Pharmaceutical Supply Chain November 20, 2025 | Thursday | News | By Hithaishi C Bhaskar API China 2025 reinforcing its position as a central hub for the global pharmaceutical …
• US vulnerable to China's API dominance, says report November 19, 2025 11:38 am pharmaphorum China has such a dominant position in active pharmaceutical ingredient (API) production that there is a risk it could "weaponise" access, according to a new congressional report. The document, from the US-China Economic and Security Review …
• Quid Pro Quo? How Washington and Big Pharma Are Partnering Up to Lower Drug Prices and Abate Tariffs in Return for U.S. Investments November 18, 2025 3:11 am Healthcare Packaging Key Takeaways: ·      In return for their investment in U.S. manufacturing, the administration would drop a proposed 100% tariffs on branded and patented drugs imported to the U.S. ·      Trump’s push for most-favored-nation aims to lower the price of …
• Shilpa Pharma Lifesciences 憑藉卓越可持續發展實踐 榮獲 EcoVadis 金獎 November 17, 2025 8:37 pm Macau Business 印度賴久爾 2025年11月17日 /美通社/ — Shilpa Medicare Limited（孟買證券交易所：530549）（印度國家證券交易所股票代碼：SHILPAMED）旗下的重要子公司 Shilpa Pharma Lifesciences Limited 宣佈，榮獲全球最受信賴的商業可持續發展評級機構 EcoVadis 頒發享負盛名的金獎。 該公司獲得 82/100 的優異評分，在 EcoVadis 評估的全球超過 130,000 間企業中，位列第 98 …
• Eagle Forum of Alabama, API cheer U.S. Senate closing ‘dangerous intoxicating hemp’ loophole November 12, 2025 1:27 pm 1819 News On Tuesday, Alabama conservative groups applauded the U.S. Senate for including a ban on "intoxicating hemp-derived drugs," such as Delta-8 THC, in legislation to reopen the federal government. The legislation closed a "loophole" …
• Top stocks in news: Lenskart, Bajaj Auto, HAL, Trent, Nykaa, Nalco, Swiggy, Lupin, Medanta November 10, 2025 4:35 am Business Today Indian benchmark indices settled mildly lower on Friday as they staged a strong rebound from day's low amid muted domestic and global cues. BSE Sensex retreated 94.73 points, or 0.11 per cent, to settle at 83,216.28, while NSE's Nifty50 tumbled 17. …
• The Analyst Verdict: Amphastar Pharma In The Eyes Of 4 Experts November 7, 2025 1:05 pm Benzinga Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Amphastar Pharma (NASDAQ:AMPH) in the last three months. The table below summarizes their recent ratings, showcasing the evolving sentiments within the …
• <![CDATA[Pharma Pulse: Cholesterol Imbalance Tied to Depression Risk, Lilly Acquires Aderum Biotechnologies, and Cambrex Expands API Manufacturing]]> October 27, 2025 12:47 pm Pharmaceutical Commerce Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and in today’s episode, we’re exploring new …
• China’s Pharma Leverage Is ‘Nuclear Option’ in US Trade Talks October 24, 2025 10:06 am Yahoo Finance (Bloomberg) -- President Xi Jinping’s stranglehold on rare earths will give China unprecedented leverage to win concessions from the US during talks this weekend in Kuala Lumpur. Sitting in Beijing’s reserve is control over an even more vital supply chain: …
• Choice bullish on Laurus Labs: Pharma stock slips 4%; brokerage sees 19% upside potential October 24, 2025 7:44 am Business Today Shares of Laurus Labs dropped as much as 3.7 per cent on Friday to touch a day’s low of Rs 901.85 on the BSE, declining from its previous close of Rs 936.75. At last check, the scrip was trading 2.86 per cent lower at Rs 910. Brokerage Choice Institutional …
• Merck KGaA to mothball operations at Ireland API plant by end of 2028 October 23, 2025 1:20 am Fierce Pharma As a newly christened manufacturing facility comes online in one part of Ireland, Merck KGaA plans to turn out the lights at another roughly three hours north. Merck KGaA plans to discontinue operations at its production plant in Arklow, Ireland, “by the …
• API China returns with 93rd edition to strengthen its role as Asia’s pharma powerhouse October 22, 2025 9:03 am Biospectrum Asia API China returns with 93rd edition to strengthen its role as Asia’s pharma powerhouse October 22, 2025 | Wednesday | News One of the largest gatherings of the pharmaceutical supply chain is staged at the Chongqing International Expo Center from 12–14 …
• World News | Indian Firms Look to Localise Pharma Production in Russia October 17, 2025 8:04 am Latestly Moscow [Russia], October 17 (ANI): The Russian market is attracting growing interest from Indian pharmaceutical companies exploring opportunities to establish production facilities across various regions of the country. This was announced by Moscow …
• AstraZeneca sets $4.5bn Virginia API plant construction in motion October 10, 2025 1:04 pm Pharmaceutical Technology AstraZeneca has commenced construction of its $4.5bn active pharmaceutical ingredient (API) manufacturing facility in Virginia. The site, which is located near Charlottesville, will produce APIs for medicines across its cardiovascular, obesity, oncology …
• Sun Pharma shares in focus as NCLT clears merger of subsidiaries; details here October 9, 2025 4:12 am Business Today Shares of Sun Pharma are in focus on Thursday after the National Company Law Tribunal (NCLT), Ahmedabad Bench, approved the Composite Scheme of Arrangement, the company said in a filing to the stock exchanges.  The exchange intimation, dated October 8, …
• Target prices for Sun Pharma, Lupin, Dr Reddy's, Zydus Life, Cipla: Q2 preview October 8, 2025 6:13 am Business Today Brokerage firm Choice Institutional Equities expects a mixed quarter for pharmaceutical companies in Q2 FY26, with domestic operations likely to outperform even as growth in the US moderates. The brokerage has maintained a ‘Positive’ sector view, …
• Mitigating Disruptions in API Supply: Building Resilient and Redundant Sourcing Strategies October 8, 2025 12:16 am Contract Pharma Global active pharmaceutical ingredient (API) supply chains continue to face persistent challenges from post-pandemic disruptions, shifting geopolitical dynamics, and evolving regulations. Longer lead times, raw material shortages, and manufacturing …
• Uzbekistan's Pharma Agency Views Investment Shots With South Korea's Sang-A October 7, 2025 6:59 am MENAFN (MENAFN- Trend News Agency) TASHKENT, Uzbekistan, October 6. Uzbekistan's Agency for the Development of the Pharmaceutical Sector held a meeting with a delegation from South Korea's Sang-A Pharmaceutical to discuss potential investment and …
• Active Pharmaceutical Ingredients (API) Market to Surpass US$ 428.5 Billion by 2033 as Biotech APIs and Oncology Applications Lead Global Growth | DataM Intelligence October 3, 2025 10:41 am WFMZ - Pennsylvania AUSTIN, Texas and TOKYO, Oct. 3, 2025 /PRNewswire/ -- According to DataM Intelligence, the Active Pharmaceutical Ingredients Market Size reached US$ 238.7 Billion in 2024, up from US$ 224.7 Billion in 2023, and is projected to grow to US$ 428.5 …
• Bitter pill: Trump's tariff spooks investors of these three pharma giants October 3, 2025 6:59 am Mint In this article we discuss three Indian pharma stocks that have been affected by the news. We wish to emphasise that this is not an analysis of the nature of impact, since the details are unclear. For example, does it exempt companies that already have a …
• Business News | Who's Investing in Unlisted Shares--and Why the Retail Crowd is Catching Up September 30, 2025 6:37 am Latestly PNN New Delhi [India], September 30: Investing in unlisted companies--essentially buying shares before they are listed on the stock exchange--is gaining significant traction in India. The appeal is clear: investors can potentially earn in two ways, first, …
• Trump's 100% Drug Tariff Unlikely To Hurt India's Pharma Exports, Say Industry Officials September 26, 2025 9:15 am News18 Last Updated:September 26, 2025, 12:10 IST Industry watchers caution that the final impact hinges heavily on the tariff’s fine print Donald Trump on Friday announced sweeping new tariffs of 100 per cent on imports of branded and patented pharmaceutical …
• India Active Pharmaceutical Ingredients (API) Industry Report 2025-2030: Competitive Analysis of Aurobindo, Divi's, Dr. Reddy's, GSK, Lupin, Novartis, Pfizer, Sanofi, Sun Pharma, Boehringer Ingelheim - ResearchAndMarkets.com September 23, 2025 1:40 pm Voice of Alexandria - Minnesota DUBLIN--(BUSINESS WIRE)--Sep 23, 2025-- The "Active Pharmaceutical Ingredients Industry in India (2025 - 2030)" report has been added to ResearchAndMarkets.com's offering. In 2023, the active pharmaceutical ingredient (API) industry in India …
• Aurobindo Pharma incorporates new wholly owned subsidiary in Malaysia September 19, 2025 10:51 pm Biospectrum Asia Aurobindo Pharma incorporates new wholly owned subsidiary in Malaysia September 19, 2025 | Friday | News To expand pharmaceutical products business in Malaysia image credit- shutterstock Aurobindo Pharma (Malaysia) SDN. BHD. has been incorporated as a …
• Business News | Anurag University Signs MoU with MSN Laboratories September 17, 2025 11:39 am Latestly VMPL Hyderabad (Telangana) [India], September 17: Anurag University has further strengthened its industry partnerships by signing a Memorandum of Understanding (MoU) with MSN Laboratories Limited, one of India's leading pharmaceutical companies. The …